QIAGEN NV (QGEN)
NYSE • Healthcare
Last close at July 21, 2026 at 20:00 UTC
Fundamentals Charts
About QIAGEN NV
Qiagen N.V. (NYSE: QGEN) develops molecular testing and life-science tools for healthcare and research use, spanning diagnostic assays, laboratory consumables, instruments, and software. In FY2025, the company generated $2.1 billion in revenue. It serves the medical diagnostics and research market worldwide.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
QIAGEN NV's Technical Indicators Summary
QGEN is trading around 41.15 with a generally bullish technical posture driven by positive momentum and MACD, and multiple short- and medium-term moving averages beneath the price. RSI is elevated but not extreme and ADX above 30 suggests the trend has strength. The 200-day average remains slightly above current price, indicating some longer-term resistance, and on-balance volume readings are mixed despite the buy signals from momentum. Volatility is contained. Technical takeaway: Buy — strong medium-term trend and positive momentum, tempered by the 200-day level overhead.
| Indicator | Value |
|---|---|
RSI (14) | 60.91 |
Stochastic %K (14, 3, 3) | 56.94 |
CCI (20) | 82.96 |
WPR (14) | -45.43 |
Momentum (10) | 1.05 |
MFI | 56.90 |
MACD Level (12, 26) | 1.16 |
Bollinger Bands | $36.20 - $42.99 |
ATR (14) | $1.22 (2.98%) |
ADX (14) | 30.17 |
OBV | -29,341,319 |
Classic Pivot Point | $41.48 |
Fibonacci Pivot Point | $41.48 |
Exponential Moving Averages | $38.76 - $42.71(5 indicators) |
Simple Moving Averages | $37.10 - $43.59(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The day concluded with QGEN hovering close to the prior 40.48, holding a tiny 0.09% gap. The session closed with mild sector strength (0.63%), slightly supporting risk appetite. QGEN trades steady as recent results highlight margin resilience.
Trading Volume
Below 10d avg (3.6M)
1.8M
vs S&P 500 Today
Underperforming Market
-0.81%
52-Week Position
Lower range
31.6%
Updated: July 21, 2026 at 20:06 UTC